News
Origin of oesophageal cancer cells revealed
12 Aug 2021
Discovery of origin of oesophageal cancer cells highlights importance of screening for pre-cancerous Barrett’s oesophagus.
Cytosponge adopted in Scotland
8 Jul 2021
NHS Scotland adopts the Cytosponge to diagnose and monitor people at risk of oesophageal cancer.
Cambridge researchers in four shortlisted Cancer Grand Challenge teams
21 Jun 2021
Centre scientists are leading, or part of, four shortlisted teams competing for Cancer Grand Challenges awards!
Targeting kidney cancer screening at people at higher risk shows promise
16 Jun 2021
Recent work at the University of Cambridge on kidney cancer screening, led by Dr Juliet Usher-Smith and Professor Grant Stewart and funded by Kidney Cancer UK, reveals positive public attitudes towards a potential screening programme.
Mobile unit offers Cytosponge test
9 Jun 2021
Cambridge GPs host the UK’s first mobile testing unit for people at risk of oesophageal cancer.
Two Centre members elected to EMBO
8 Jun 2021
Congratulations to Prof Rebecca Fitzgerald and Dr John Marioni who have been elected as EMBO members in recognition of their outstanding life science research.
Cambridge researchers awarded the Millennium Technology Prize
18 May 2021
British duo Professor Shankar Balasubramanian and Professor David Klenerman have been awarded the Millennium Technology Prize for their development of revolutionary DNA sequencing techniques.
New cancer algorithm flags genetic weaknesses in tumours
27 Apr 2021
A new way to identify tumours that could be sensitive to particular immunotherapies has been developed using data from thousands of NHS cancer patient samples sequenced through the 100,000 Genomes Project.
Using AI to analyse Cytosponge samples
15 Apr 2021
Artificial intelligence could ease pressures on diagnostic services for precancerous condition, Barrett’s oesophagus.
Artificial intelligence techniques could help with earlier diagnosis of cancer in primary care: a systematic review
3 Mar 2021
Artificial Intelligence (AI) techniques can be applied to primary care data to facilitate the early diagnosis of cancer, according to the first international review of studies on this topic.